The Simply Good Foods Company
$1.16B- Market cap
- $1.01B
- Debt
- +$249.07M
- Cash
- −$98.47M
Capital structure 80% equity / 20% debt · EV / Revenue 0.80x · EV / EBITDA 6.26x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SMPL stock price vs CTXR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTXR's multiple
Needs CTXR P/E.
Implied fair value · at SMPL's multiple
Needs EPS (TTM) is negative, SMPL P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SMPL FY 2025 (ended Aug 30, 2025) · CTXR FY 2022 (ended Sep 30, 2022). Fiscal years are not aligned.
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 80% equity / 20% debt · EV / Revenue 0.80x · EV / EBITDA 6.26x
Capital structure 161% equity / -61% debt · EV / EBITDA 0.96x
SMPL carries the larger enterprise value at $1.16B against -$31.69M; CTXR trades on the lower EV / EBITDA multiple (0.96x vs 6.26x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The Simply Good Foods Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Citius Pharmaceuticals, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.14x
-0.06x
Net debt / EBITDA
Leverage against operating earnings
0.81x
1.45x
Cash and equivalents
Liquid reserves on the balance sheet
$98.47M
$41.71M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Mondelez International, Inc.
SMPL vs MDLZ
HERSHEY CO
SMPL vs HSY
Post Holdings, Inc.
SMPL vs POST
HAIN CELESTIAL GROUP INC
SMPL vs HAIN
Zomedica Corp.
SMPL vs ZOM
Aquestive Therapeutics, Inc.
SMPL vs AQST
ACADIA PHARMACEUTICALS INC
SMPL vs ACAD
AMGEN INC
SMPL vs AMGN
GILEAD SCIENCES, INC.
SMPL vs GILD
AbbVie Inc.
SMPL vs ABBV
$249.07M
-$6.11M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.